1. Home
  2. Live Updates
  3. Repotrectinib Receives NMPA Approval in China for ROS1+ NSCL

Repotrectinib Receives NMPA Approval in China for ROS1+ NSCL

Repotrectinib Receives NMPA Approval in China for ROS1+ NSCLC

Repotrectinib Receives NMPA Approval in China for ROS1+ NSCLC

onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Shanghai , Jiaotong , Guizhou , Rafaelg Amado , , Drug Administration , Zai Lab , China National Medical Products Administration , Lung Cancer Center At Shanghai Chest Hospital , Shanghai Jiaotong University , Global Oncology Research , Bristol Myers Squibb , National Medical Products Administration , Lung Cancer Center , Shanghai Chest Hospital , Greater China ,